Many biostimulants look good in the lab. They stimulate gene expression. They alter hormone levels. They produce compelling graphs in controlled conditions.
Then they go into the field and nothing happens. Or results are inconsistent. Or the product performs brilliantly in one region and fails in another.
This gap between laboratory promise and field performance is the central credibility problem facing the biostimulant industry. At Brandon Bioscience, closing that gap is not a goal. It is the design principle behind everything we do.
What a Molecular Profile Actually Tells Us
Not all seaweed extracts are the same
Two products can both be labelled 100 per cent Ascophyllum nodosum extract and have almost nothing in common biologically. The extraction method changes everything. Hot alkaline extraction, cold pressing and low-temperature aqueous processing each produce different molecular profiles with different biological activities.
The bioactive oligosaccharides and polysaccharides that trigger plant responses are structurally altered by heat, pH and processing time. A product that looks, smells and pours the same as another may trigger completely different gene expression in the plant.
Brandon Bioscience’s extraction approach
Our proprietary extraction processes are designed to maximise the release and preservation of eliciting bioactives. Every batch is characterised using rigorous physicochemical analysis. This confirms that the molecular profile meets the standards required to produce the expected biological and field responses.
From Molecular Characterisation to Biological Validation
Five layers of evidence, not one
Knowing what is in a product tells you very little by itself. You need to know what it does inside the plant.
Brandon Bioscience characterises every product across five layers: phenotypical responses, physiological responses, biochemical responses, protein synthesis patterns and gene expression data. Together, these layers map the full picture of how a product interacts with the plant.
From laboratory to field: a traceable chain
Take BLOCSAL®. Its biological validation data confirms upregulation of sodium transporter genes, accumulation of proline and sucrose osmolytes, improvements in relative water content and better K+/Na+ ratios in leaf and root tissue.
These are not predictions. They are measured results from controlled experiments. They explain, mechanistically, why BLOCSAL® improves yield under saline irrigation.
Salinity Stress Solutions page.
The Functional Characterisation Layer
Biology confirmed in the field, not just the lab
Biological validation shows a product activates the right pathways. Functional characterisation goes further. It confirms those activated pathways produce the intended agronomic outcome under realistic growing conditions: real yield, real quality, real stress.
Why staged development produces high win rates
Every PSI® Technology product moves through glasshouse trials and controlled environments before it reaches open field testing. By the time a product enters commercial trials, there is already a strong evidence base predicting its behaviour.
This is why the win rates are so high. BARRAMAR® has achieved a 90 per cent win rate across 199 trials since 2009. MARTELLO® has recorded 82 per cent across 73 trials over 13 years. These numbers reflect a development process, not luck.
PCR-Based Quality Assurance: Molecular Accountability at Scale
Every batch tested for biological activity
SEALICUT® with PSI® 759 Precision Technology sets the standard for product-level accountability. Every single batch is PCR-tested to confirm it downregulates INDEHISCENT (IND), the master gene controlling pod shatter in oilseed rape and soybean.
This is not a compositional check. It is a direct test of the specific biological mechanism that delivers the agronomic benefit. If the batch does not pass, it does not ship.
A standard the rest of the industry has not reached
No other biostimulant manufacturer does this at commercial scale. It reflects a philosophy of molecular accountability that runs through every stage of how we develop and manufacture our products.
17 Peer-Reviewed Publications and Why That Matters
Independent validation is the only kind that counts
Brandon Bioscience invests 15 per cent of annual turnover in research and development. The result is 17 peer-reviewed publications across journals including Frontiers in Plant Science, the Journal of Agronomy, Plant Physiology and Biochemistry and Scientific Reports.
Peer review means independent scientists, with no commercial interest in the outcome, evaluated the methodology and accepted the findings. That is a fundamentally different standard from in-house trial data or product brochures.
What this means for growers and agronomists
When you recommend a PSI® Technology product, you are not asking a grower to trust a claim. You are offering them a chain of independently verified evidence that runs from molecular composition all the way to field result.
That is a different conversation. And it leads to better outcomes.
Discover Products Built on Real Science
Every PSI® Technology product carries a complete evidence chain: from molecular composition, to gene expression, to field-validated yield. All of it independently reviewed and published.
Our Science page, browse the full range on Our Solutions page, or contact our team to discuss how PSI® Technology can support your growers.
